BRIEF published on 03/03/2026 at 19:40, 6 months 13 days ago ABIONYX: Information on voting rights and shares as of February 28, 2026 Euronext Paris Share Capital Voting Rights AMF ABIONYX
BRIEF published on 03/03/2026 at 19:40, 6 months 13 days ago ABIONYX Announces February Voting Rights Update Euronext Paris Voting Rights AMF Regulations ABIONYX Pharma February 2026
PRESS RELEASE published on 03/03/2026 at 19:35, 6 months 13 days ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement of total voting rights and shares on Euronext Paris. Company focuses on innovative medicines with lipid science expertise Euronext Paris Shares Total Voting Rights ABIONYX Pharma Innovative Medicines
BRIEF published on 02/04/2026 at 19:58, 7 months 12 days ago Voting rights and shares of ABIONYX on Euronext Paris Euronext Paris Share Capital Voting Rights AMF ABIONYX
BRIEF published on 02/04/2026 at 19:58, 7 months 12 days ago ABIONYX Reports Monthly Voting Rights and Shares Update Euronext Paris Share Capital Voting Rights AMF Regulations ABIONYX Pharma
PRESS RELEASE published on 02/04/2026 at 19:53, 7 months 12 days ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement on total voting rights and shares. Company focuses on innovative medicines in rare diseases with lipid science expertise Shares Total Voting Rights Monthly Statement ABIONYX Pharma Innovative Medicines
BRIEF published on 01/28/2026 at 18:53, 7 months 19 days ago ABIONYX: Publication of the Number of Voting Rights and Shares Euronext Paris Share Capital Voting Rights Financial Transparency ABIONYX
BRIEF published on 01/23/2026 at 19:05, 7 months 24 days ago ABIONYX Pharma unveils its 2026 financial calendar Critical Care Innovative Therapies ABIONYX Pharma Sepsis Financial Calendar 2026
BRIEF published on 01/23/2026 at 19:05, 7 months 24 days ago ABIONYX Pharma Announces 2026 Financial Calendar Financial Calendar Biopharma ABIONYX Pharma 2026 Updates Sepsis Care
PRESS RELEASE published on 01/23/2026 at 19:00, 7 months 24 days ago Inside Information / Other news releases ABIONYX Pharma announces its financial calendar for 2026, including key events and dates for cash position updates and results releases Financial Calendar ABIONYX Pharma Sepsis 2026 Therapeutic Era
Published on 09/17/2026 at 12:00, 25 minutes ago Banyan Gold Intersects 1.05 g/t Gold over 52.8 metres and Bonanza-Grade Gold at Powerline Deposit, AurMac, Yukon, Canada
Published on 09/17/2026 at 10:00, 2 hours 25 minutes ago Eagle Plains Reports Additional Results from Drilling at the Don Lake Uranium Project, Saskatchewan
Published on 09/16/2026 at 23:45, 12 hours 40 minutes ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 14 hours 55 minutes ago Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 19 hours 30 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/17/2026 at 12:15, 10 minutes ago BDStar Hosted 2026 Ecosystem Partner Conference in Munich, Germany
Published on 09/17/2026 at 11:30, 55 minutes ago EyeROV: Indian Deep-Tech Startup Showcases its Underwater Drones to World Leaders
Published on 09/17/2026 at 11:00, 1 hour 25 minutes ago ABB Ltd: ABB share buybacks - September 10, 2026 - September 16, 2026
Published on 09/16/2026 at 17:45, 18 hours 40 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 5 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 18 hours ago Report on the Combined General Meeting of the 10th of September 2026
